A comparative study of two different local anaesthetic drugs given epidurally for relieving postoperative pain after major abdominal cancer surgery.

A Comparative Study of ropivacaine with fentanyl and bupivacaine with fentanyl for postoperative epidural analgesia after major abdominal oncosurgery.

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2016/06/007039

Enrollment

Registered

2016-06-24

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients Undergoing Major Abdominal Oncosurgery

Interventions

Intervention1: Ropivacaine: Epidural 0.1% Ropivacaine with Fentanyl (2microgram/ml)Postoperatively Control Intervention1: Bupivacaine: Epidural 0.1%Bupivacaine with Fentanyl(2 microgram/ml)postoperati

Eligibility

Inclusion criteria

Inclusion criteria: Weight between 45-75 Kg ASA Physical Status I, II and III Elective major oncosurgery via a vertical, midline infraumbilical incision

Exclusion criteria

Exclusion criteria: Patient refusal for Regional Anaesthesia Contraindications for Regional Anaesthesia(coagulopathy,regional infection) History of allergic reaction to Bupivacaine, Ropivacaine or Fentanyl Spinal deformity

Design outcomes

Primary

Measure	Time frame
VAS score for postoperative painTimepoint: 10mins,1hour,6hour,12hour,18 hour and 24 hour	—

Secondary

Measure	Time frame
Bromage Score for motor blockadeTimepoint: 10 mins,1hour,6 hours,12 hours,18 hours and 24 hours	—

Countries

India

Contacts

Public ContactShagun Bhatia Shah

Rajiv Gandhi Cancer Institute and Research Centre

drshagun_2010@rediffmail.com9891769779

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026